首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1705664

全EXOME市场：按产品类型、按技术、按应用、按适应症、按最终用户、按地区

Whole Exome Sequencing Market, By Product Type, By Technology, By Application, By Indication, By End User, By Geography

出版日期: 2025年02月11日 | 出版商:

Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025年全球全EXOME定序市场规模估计为20.7亿美元，预计到2032年将达到55.1亿美元，2025年至2032年的年复合成长率（CAGR）为15.0%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	20.7亿美元
效能数据	2020-2024	预测期	2025-2032
预测期：2025-2032年复合年增长率：	15.00%	2032年价值预测	55.1亿美元

数字。 2025年全外EXOME定序市场占有率（%），依地区划分

全EXOME定序是一种强大的技术，可以分析基因的整个蛋白质转录区以检测致病的遗传变异。近年来，它彻底改变了临床诊断和基因研究。由于癌症研究应用的不断增加、个人化医疗需求的不断增长以及全基因组定序相对于传统定序技术的日益普及，预计整个EXOME序市场将显着成长。

市场动态：

全球全EXOME定序市场受到慢性病盛行率上升、研究活动资金增加、全EXOME序在药物发现的应用不断扩大以及精准医疗的推动。然而，预算限制、对熟练人力的需求以及缺乏适当的报销政策限制了市场的成长。新兴经济体、持续的技术进步以及产学研合作的加强为市场提供了机会。

本研究的主要特点

本报告对全球EXOME定序市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），假设基准年为 2024 年。

它揭示了各个领域的潜在商机，并解释了该市场的引人注目的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。

全球全EXOME定序市场的主要企业是根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行的分析。

研究中介绍的主要企业包括 Illumina, Inc.、Thermo Fisher Scientific Inc.、BGI Genomics、Agilent Technologies, Inc.、Roche Diagnostics、QIAGEN NV、Pacific Biosciences of California, Inc.、Oxford Nanopore Technologies plc、Eurofins Scients Scients、Kanmb集、Holec. Hoffmann-La Roche Ltd.、Laboratory Corporation of America Holdings 与 Novogene Corporation。

本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴车型、市场扩张和行销策略做出明智的决策。

全球全外EXOME定序市场报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员可以透过分析全球全EXOME定序市场所使用的各种策略矩阵来促进他们的决策。

Illumina, Inc.
Thermo Fisher Scientific Inc.
BGI Genomics
Agilent Technologies, Inc.
Roche Diagnostics
QIAGEN NV
Pacific Biosciences of California, Inc.
Oxford Nanopore Technologies plc
Eurofins Scientific SE
Genomatix GmbH
Myriad Genetics, Inc.
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd
Laboratory Corporation of America Holdings
Novogene Corporation

第 11 章分析师建议

命运之轮
分析师观点
一致的机会图

第十二章参考文献与调查方法

参考
调查方法
关于出版商

简介目录

Product Code: CMI7571

Global Whole Exome Sequencing Market is estimated to be valued at USD 2.07 Bn in 2025 and is expected to reach USD 5.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.0% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 2.07 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	15.00%	2032 Value Projection:	USD 5.51 Bn

Figure. Whole Exome Sequencing Market Share (%), By Region 2025

Whole exome sequencing is a powerful technology that allows analyzing the entire protein-coding region of genes in order to detect genetic variations responsible for diseases. It has revolutionized clinical diagnosis and genetic research in recent years. Whole exome sequencing market is expected to experience significant growth due to rising applications in cancer research, increasing demand for personalized medicine, and growing popularity of whole genome sequencing over traditional sequencing techniques.

Market Dynamics:

The global whole exome sequencing market is driven by rising incidence of chronic diseases, increased funding for research activities, growing applicability of whole exome sequencing in drug discovery, and precision medicine. However, budget constraints, requirement of skilled personnel and non-availability of adequate reimbursement policies limit the market growth. The market provides opportunities for players due to emerging economies, continuous technological advancements, and increasing collaborations between industry and academia.

Key Features of the Study:

This report provides in-depth analysis of the global whole exome sequencing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global whole exome sequencing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Illumina, Inc., Thermo Fisher Scientific Inc., BGI Genomics, Agilent Technologies, Inc., Roche Diagnostics, QIAGEN N.V., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies plc, Eurofins Scientific SE, Genomatix GmbH, Myriad Genetics, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, and Novogene Corporation

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global whole exome sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global whole exome sequencing market

Market Segmentation

By Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Instruments
- Consumables
- Services
By Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Other Technologies
By Application Insights (Revenue, USD Bn, 2020 - 2032)
- Drug Discovery & Development
- Clinical Diagnostics
- Research
By Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Cancer
- Rare/Inherited Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Others
By End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals & Clinics
- Diagnostics Laboratories
- Academic and Research Institutes
- Biopharmaceutical Companies
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- BGI Genomics
- Agilent Technologies, Inc.
- Roche Diagnostics
- QIAGEN N.V.
- Pacific Biosciences of California, Inc.
- Oxford Nanopore Technologies plc
- Eurofins Scientific SE
- Genomatix GmbH
- Myriad Genetics, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Laboratory Corporation of America Holdings
- Novogene Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Whole Exome Sequencing Market, By Product Type
- Global Whole Exome Sequencing Market, By Technology
- Global Whole Exome Sequencing Market, By Application
- Global Whole Exome Sequencing Market, By Indication
- Global Whole Exome Sequencing Market, By End User
- Global Whole Exome Sequencing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Whole Exome Sequencing Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Whole Exome Sequencing Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Sequencing by Synthesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ion Semiconductor Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Whole Exome Sequencing Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Drug Discovery & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Whole Exome Sequencing Market, By Indication, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Rare/Inherited Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Whole Exome Sequencing Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostics Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Whole Exome Sequencing Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
BGI Genomics
Agilent Technologies, Inc.
Roche Diagnostics
QIAGEN N.V.
Pacific Biosciences of California, Inc.
Oxford Nanopore Technologies plc
Eurofins Scientific SE
Genomatix GmbH
Myriad Genetics, Inc.
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd
Laboratory Corporation of America Holdings
Novogene Corporation

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

全EXOME市场：按产品类型、按技术、按应用、按适应症、按最终用户、按地区